Internal Medicine, Infectious Disease · Stuart, FL
NPI
1588624191
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
509 SE Riverside Dr Ste 201
Stuart, FL, 34994
Phone (722) 212-0737
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
970 services
Medicare patients, 2024
503
Average age 78
Drug cost, 2024
$397K
553 prescriptions
Company payments, 2025
$125
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lyssette L Cardona-Bonet was code 99233 (hospital e&m - subsequent), 410 times for 288 patients. In total Lyssette L Cardona-Bonet billed 970 services in 20 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 410 | 288 | $96.29 | $39K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 125 | 81 | $13.54 | $1,692 |
| 99214 Office E&M - Established | Office | 87 | 67 | $103.82 | $9,032 |
| 99232 Hospital E&M - Subsequent | Facility | 83 | 73 | $64.55 | $5,358 |
| 99223 Hospital E&M - Initial | Facility | 53 | 53 | $143.21 | $7,590 |
| 99215 Office E&M - Established | Office | 45 | 32 | $144.21 | $6,489 |
| 99213 Office E&M - Established | Office | 37 | 36 | $73.99 | $2,738 |
| 99222 Hospital E&M - Initial | Facility | 33 | 33 | $108.79 | $3,590 |
| 99204 Office E&M - New | Office | 28 | 28 | $134.94 | $3,778 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 16 | 16 | $86.66 | $1,387 |
| 99203 Office E&M - New | Office | 12 | 12 | $92.98 | $1,116 |
By year: 2022 $47K for 428 services; 2023 $56K for 551 services; 2024 $86K for 970 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lyssette L Cardona-Bonet prescribed most often to Medicare patients was Sodium Chloride (0.9 % Sodium Chloride), with 54 prescriptions and refills. In total Lyssette L Cardona-Bonet wrote 553 Medicare prescriptions that cost $397K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sodium Chloride 0.9 % Sodium Chloride | 54 | 54 | 15 | $321 |
| Amikacin Sulfate Generic | 51 | 51 | Under 11 | $3,469 |
| Azithromycin Generic | 45 | 59 | 12 | $1,145 |
| Ethambutol Hcl Generic | 39 | 49 | Under 11 | $1,727 |
| Ertapenem Ertapenem Sodium | 29 | 29 | 13 | $13K |
| Ceftriaxone Ceftriaxone Sodium | 27 | 27 | 14 | $2,832 |
| Arikayce Amikacin Liposomal/Neb.Accessr | 21 | 21 | Under 11 | $308K |
| Cefazolin Sodium Generic | 21 | 21 | Under 11 | $449 |
| Ciprofloxacin Hcl Generic | 20 | 22 | 13 | $206 |
| Rifampin Generic | 19 | 23 | Under 11 | $651 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 19 | 19 | Under 11 | $478 |
| Daptomycin Generic | 19 | 19 | Under 11 | $9,104 |
| Methenamine Hippurate Generic | 18 | 30 | Under 11 | $1,303 |
| Acyclovir Generic | 14 | 14 | Under 11 | $142 |
| Doxycycline Hyclate Generic | 13 | 15 | Under 11 | $876 |
Brand drugs: 98 claims; generic drugs: 455 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lyssette L Cardona-Bonet $125 ($125 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $125.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $125 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.